ArticleLeukemia2025

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.

Bijal D Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.